Therapy of steroid-refractory acute GVHD with CD52 antibody alemtuzumab is effective.
Schub
N
N
Division for Stem Cell Transplantation and Immunotherapy, Second Department of Medicine, Kiel, Germany.
Günther
A
A
Schrauder
A
A
Claviez
A
A
Ehlert
C
C
Gramatzki
M
M
Repp
R
R